Ikobel

Tobramycin, the active ingredient in Ikobel, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye such as conjunctivitis and keratitis in patients requiring prescription therapy. The formulation is designed for topical application to the conjunctival sac, delivering high local concentrations while minimizing systemic exposure.

GNH USA supplies Ikobel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Tobramycin is an aminoglycoside antibiotic used to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and alleviates inflammation in the conjunctiva. - Keratitis: eradicates pathogenic bacteria causing corneal infection and promotes healing. - Post‑operative ocular infection: helps prevent or treat bacterial contamination after eye surgery. - Other ocular bacterial infections: provides broad‑spectrum coverage for various bacterial eye conditions.

Adverse reactions may occur following ocular administration of Tobramycin.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Excessive tearing or discharge. - Blurred vision. - Foreign body sensation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic reaction (e.g., swelling, rash, anaphylaxis). - Corneal ulceration or severe keratitis. - Significant eye pain or vision loss. - Systemic absorption leading to nephrotoxicity. - Ototoxicity (rare with ocular use). - Persistent intraocular inflammation.

Before using Ikobel, consider the following safety measures.

- Assess for hypersensitivity: discontinue if signs of allergic reaction appear. - Evaluate renal function: use caution in patients with impaired kidney function. - Monitor for ototoxicity: be alert for hearing changes, especially with prolonged use. - Avoid concurrent use with other aminoglycoside eye drops unless directed. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Tobramycin may interact with other medications administered to the eye or systemically.

Major Interactions (Avoid): - Other aminoglycoside ophthalmic preparations: increased risk of toxicity. - Loop diuretics (e.g., furosemide): may potentiate nephrotoxic effects if systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Other ophthalmic antibiotics: assess for additive toxicity. - Systemic nephrotoxic agents (e.g., vancomycin, amphotericin B): monitor renal function.